Company: BLNE
Filing Date: 2025-03-27
Form Type: 424B7
Source: 0001641172-25-000822
Chunk: 7

Company: Beeline Holdings, Inc.
Filing Date: 2025-03-27
Form: 424B7
Chunk 7
---
 selling stockholder pursuant to the Purchase Agreement and               
 this prospectus supplement. Because of the amount of proceeds we may receive is based on our future stock prices and volume, the        
 amount of proceeds we will receive may be less or more.                                                                                 |
| Nasdaq Capital Market           
 symbol                          |     | “BLNE”                                                                                                                                  |
| Risk factors                    |     | This investment involves                                                                                                                
 a high degree of risk. See “Risk Factors” on page S-14 of this prospectus supplement and incorporated by reference into this            
 prospectus supplement, and the other reports incorporated by reference into the accompanying prospectus for a discussion of factors you 
 should carefully consider before deciding to invest in our common stock.                                                                |

| S-9 |

The number of shares common stock to be outstanding immediately after this offering is based on 7,211,944 shares of common stock outstanding as of March 25, 2025 and excludes, as of that date:

| ● | An                                                                         
 estimated 2,331,187                                                        
 shares of common stock underlying outstanding convertible preferred stock; |

| ● | 704,543                                                                     
 shares of common stock issuable upon the exercise of outstanding warrants ; |

| ● | 105                                                                                 
 shares of common stock issuable upon the exercise of outstanding stock options; and |

| ● | Up                                                                                   
 to 1,200,000 shares of common stock available for issuance pursuant to the Company’s 
 2025 Equity Incentive Plan.                                                          |

The share amounts, and conversion and exercise prices reflected above and elsewhere in this prospectus supplement give effect to the 1-for-10 reverse stock split which was effected at 12:01 am ET on March 12, 2025. Share amounts and prices do not give effect to (i) sales which may be made under the Purchase Agreement including under prior prospectus supplements filed on March 10, 2025 and March 26, 2025, (ii) an estimated 388,785 options and an estimated 28,710 warrants which we are obligated to issue to former Beeline option holders and warrant holders, respectively, as a result of the Merger, or (iii) potential adjustment to the numbers of conversion and exercise prices and underlying shares pursuant to provisions in the respective securities described herein.

<div align='center'>THE PURCHASE AGREEMENT</div>

On December 31, 2024, we entered into a Common Stock Purchase Agreement, as amended and restated on March 7, 2025